Evidence map›Paper›PMID 31330953›Full record

ArticleInternational journal of molecular sciences2019

Simvastatin Efficiently Reduces Levels of Alzheimer's Amyloid Beta in Yeast.

Sudip Dhakal, Mishal Subhan, Joshua M Fraser, Kenneth Gardiner, Ian Macreadie

Open access · goldAbstract read
In one paragraph

Article in International journal of molecular sciences, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 17 papers.

0numbers the graph read from it
0cells of the map it votes in
17citing papers in PubMed
3.1field-weighted citation impact, top 8% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

17 citing papers in PubMed, 35 citations in OpenAlex.

  1. Review
  2. Article
  3. Review
  4. Review
  5. Review
  6. Alzheimer's Disease: Significant Benefit from the Yeast-Based Models.International journal of molecular sciences · 2023
    Review
  7. Molecular Mechanisms of Alzheimer's Disease III.International journal of molecular sciences · 2022
    Article
  8. The Use of Yeast in Biosensing.Microorganisms · 2022
    Review
  9. Review
  10. International journal of molecular sciences · 2021
    Article
  11. A Toxic Synergy between Aluminium and Amyloid Beta in Yeast.International journal of molecular sciences · 2021
    Article
  12. Implications on the Therapeutic Potential of StatinsOxidative medicine and cellular longevity · 2021
    Review
  13. Review
  14. Utilization of an Industry Byproduct,Bioengineering (Basel, Switzerland) · 2020
    Article
  15. Article
  16. Review
  17. Analysis of Serum miRNAs in Alzheimer's Disease.American journal of Alzheimer's disease and other dementias
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 2 institutions in 2 countries.

Sudip DhakalSchool of Science, RMIT University, Bundoora, Victoria 3083, Australia.
Mishal SubhanSchool of Science, RMIT University, Bundoora, Victoria 3083, Australia.
Joshua M FraserSchool of Science, RMIT University, Bundoora, Victoria 3083, Australia.
Kenneth GardinerSchool of Science, RMIT University, Bundoora, Victoria 3083, Australia.
Ian MacreadieSchool of Science, RMIT University, Bundoora, Victoria 3083, Australia. ian.macreadie@rmit.edu.au.ORCID 0000-0001-5335-7220
RMIT University · AUMIT University · MK

Funding

Medical Advances Without Animals Trust Honours Scholarship
6 · The paper itself

Abstract

A large-scale epidemiology study on statins previously showed that simvastatin was unique among statins in reducing the incidence of dementia. Since amyloid beta (Aβ42) is the protein that is most associated with Alzheimer's disease, this study has focused on how simvastatin influences the turnover of native Aβ42 and Aβ42 fused with green fluorescent protein (GFP), in the simplest eukaryotic model organism,

Indexed as

AgingAlzheimer DiseaseAmyloid beta-PeptidesCellular SenescenceErgosterolGene ExpressionGene OrderGenes, ReporterHumansHydroxymethylglutaryl-CoA Reductase InhibitorsPlasmidsProteolysisRecombinant Fusion ProteinsSaccharomyces cerevisiaeSimvastatinYeastsAmyloid beta-PeptidesErgosterolHydroxymethylglutaryl-CoA Reductase InhibitorsRecombinant Fusion ProteinsSimvastatinageingAlzheimer’s diseaseamyloid betaautophagyproteostasisstatinsyeast

Identifiers

PMID31330953
PMCPMC6678968
OpenAlexW2959434627

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.